PTC Therapeutics Inc PTCT

NAS: PTCT | ISIN: US69366J2006 26/12/2025

78,56 USD (+0,24%)

(+0,24%) 26/12/2025

Grafiek PTC Therapeutics Inc

Grafiek PTC Therapeutics Inc

1 dag1d 0,24%
1 week1w -0,43%
1 maand1m -8,64%
3 maanden3m 29,53%
6 maanden6m 57,62%
1 jaar1j 73,69%
5 jaar5j 22,50%

PTC Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

22 december 2025 · PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan · Persbericht

19 december 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

18 december 2025 · PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

1 december 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

20 november 2025 · PTC Therapeutics to Host R&D Day · Persbericht

4 november 2025 · PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results · Persbericht

31 oktober 2025 · PTC Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

27 oktober 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

21 oktober 2025 · PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results · Persbericht

1 oktober 2025 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

Profiel PTC Therapeutics Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.ptcbio.com

Hoofdzetel: South Plainfield, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe